%0 Journal Article
%T Influence of MSI and 18q LOH markers on capecitabine adjuvant monotherapy in colon cancer patients
%A Aleksandar Dimovski
%A Aleksandra Kapedanovska-Nestorovska
%A Biljana Grozdanovska
%A Marija Staninova-Stojovska
%A Milco Panovski
%A Nadica Matevska-Geshkovska
%A Natalija Petrushevska-Angelovska
%A Nenad Mitreski
%J Archive of "Pharmacogenomics and Personalized Medicine".
%D 2018
%R 10.2147/PGPM.S172467
%X The aim of this study was to evaluate whether pretreatment analysis of selected molecular markers can be used for the prediction of disease-free survival (DFS)/overall survival (OS) of capecitabine adjuvant monotherapy in colon cancer patients
%K gastrointestinal cancer
%K microsatellite instability
%K 18q allelic imbalance
%K prognostic marker
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219100/